Epanova | AMRN Message Board Posts

Amarin Corporation plc

  AMRN website

AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  4402 of 4949  at  6/19/2019 12:36:53 PM  by

ex_hacker202


 In response to msg 4399 by  Sharon
view thread

Re: Epanova

  STRENGTH was "over powered" - too many patients and too short of a time spent in the trial - after R-IT results came out and showed max benefits occurred at later dates AZN extended the trial another year. Begs the question of if they'll greatly exceed the 1600 events needed and if that's ethical - only way they could extend a year and not exceed 1600 is if event rates are well below that seen in R-IT, which you'd think would be very unlikely - it would mean E has more efficacy the V, and nobody on earth expects that because of the DHA content in E.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 165
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
4403 Re: Epanova Public_Heel 5 6/19/2019 1:10:30 PM
4406 Re: Epanova Sharon 0 6/19/2019 2:23:05 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...